Jupiter Neurosciences, Common Stock Current Valuation
| JUNS Stock | USD 9.73 1.13 10.41% |
Valuation analysis of Jupiter Neurosciences, helps investors to measure Jupiter Neurosciences,'s intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to drop to -42.03 in 2024. Enterprise Value Multiple is likely to drop to -42.03 in 2024. Fundamental drivers impacting Jupiter Neurosciences,'s valuation include:
Enterprise Value 202.5 M |
Overvalued
Today
Please note that Jupiter Neurosciences,'s price fluctuation is very risky at this time. Calculation of the real value of Jupiter Neurosciences, is based on 3 months time horizon. Increasing Jupiter Neurosciences,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Jupiter stock is determined by what a typical buyer is willing to pay for full or partial control of Jupiter Neurosciences, Common. Since Jupiter Neurosciences, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Jupiter Stock. However, Jupiter Neurosciences,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.73 | Real 8.54 | Hype 10.08 |
The intrinsic value of Jupiter Neurosciences,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Jupiter Neurosciences,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Jupiter Neurosciences, Common helps investors to forecast how Jupiter stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Jupiter Neurosciences, more accurately as focusing exclusively on Jupiter Neurosciences,'s fundamentals will not take into account other important factors: Jupiter Neurosciences, Common Company Current Valuation Analysis
Jupiter Neurosciences,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Jupiter Neurosciences, Current Valuation | 202.55 M |
Most of Jupiter Neurosciences,'s fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jupiter Neurosciences, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Jupiter Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Jupiter Neurosciences, is extremely important. It helps to project a fair market value of Jupiter Stock properly, considering its historical fundamentals such as Current Valuation. Since Jupiter Neurosciences,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Jupiter Neurosciences,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Jupiter Neurosciences,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Jupiter Neurosciences, Common has a Current Valuation of 202.55 M. This is 98.59% lower than that of the Healthcare sector and 95.64% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 98.78% higher than that of the company.
Jupiter Neurosciences, Common is rated second overall in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Biotechnology industry is currently estimated at about 5.39 Billion. Jupiter Neurosciences, holds roughly 202.55 Million in current valuation claiming about 4% of stocks in Biotechnology industry.Jupiter Fundamentals
| Current Valuation | 202.55 M | ||||
| EBITDA | (4.56 M) | ||||
| Net Income | (4.78 M) | ||||
| Total Debt | 2.25 M | ||||
| Cash Flow From Operations | (480.95 K) | ||||
| Market Capitalization | 200.22 M | ||||
| Total Asset | 148.59 K | ||||
| Retained Earnings | (23.58 M) | ||||
| Net Asset | 148.59 K |
About Jupiter Neurosciences, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jupiter Neurosciences, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jupiter Neurosciences, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jupiter Neurosciences, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Jupiter Stock Analysis
When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.